Boston Scientific
904 hedge funds and large institutions have $56.8B invested in Boston Scientific in 2022 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 357 increasing their positions, 288 reducing their positions, and 84 closing their positions.
56% more funds holding in top 10
Funds holding in top 10: 9 → 14 (+5)
29% more first-time investments, than exits
New positions opened: 108 | Existing positions closed: 84
24% more repeat investments, than reductions
Existing positions increased: 357 | Existing positions reduced: 288
2% more funds holding
Funds holding: 888 → 904 (+16)
4% more capital invested
Capital invested by funds: $54.6B → $56.8B (+$2.24B)
0.3% less ownership
Funds ownership: 90.41% → 90.11% (-0.3%)
14% less call options, than puts
Call options by funds: $312M | Put options by funds: $361M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$296M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$278M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$233M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$138M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$93.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$628M |
| 2 |
Newport Trust Company
Washington,
District of Columbia
|
-$330M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$268M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$265M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$251M |
BSX Hedge Fund Activity: Q1 2022 in Review
904 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2022, worth a combined $56.8B — up 4.1% from $54.6B a quarter earlier.
Buyers outnumbered sellers: 108 funds opened new BSX positions and 84 closed out — a net gain of 24 holders — while 357 added to existing stakes and 288 trimmed.
The largest buyer was DZ Bank, adding an estimated $296M. The largest seller was Janus Henderson Group, cutting an estimated $628M.
- 904 institutional investors held Boston Scientific (BSX) as of Q1 2022, up from 888 in Q4 2021.
- Funds reported $56.8B of Boston Scientific stock for Q1 2022, up 4.1% quarter-over-quarter.
- 108 funds opened new Boston Scientific positions in Q1 2022 and 84 closed out, a net change of +24 holders.
- The largest Boston Scientific buyer in Q1 2022 was DZ Bank, an estimated $296M added.
- The largest Boston Scientific seller in Q1 2022 was Janus Henderson Group, an estimated $628M sold.
Based on aggregated 13F filings for Q1 2022.